01:38 PM EST, 02/10/2025 (MT Newswires) -- Biodexa Pharmaceuticals ( BDRX ) said Monday the US Food and Drug Administration granted fast-track designation for eRapa as a potential treatment for familial adenomatous polyposis.

Shares surged 44% as intraday trading volume catapulted to over 20.5 million from a daily average of about 139,000.

DatChat ( DATS ) disclosed Monday the upcoming launch of its Myseum platform, a digital content management and storage solution for families, groups, and individuals.

Shares jumped 10%, with intraday trading volume rising to nearly 860,000 compared with a daily average of more than 8.72 million.

Axsome Therapeutics ( AXSM ) shares surged 22% after the firm said Monday it agreed to a settlement with Teva Pharmaceuticals (TEVA) to resolve "all" patent litigation related to Auvelity.

More than 3.4 million shares traded intraday compared with a daily average of about 800,000.

Price: 5.83, Change: +1.76, Percent Change: +43.24